This inventor holds 1 USPTO granted patent. Top assignee: The Rockefeller University. Active years: 1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995
Title: Elisabeth P Sampaio: Innovator in TNF .alpha. Treatment
Introduction
Elisabeth P Sampaio is a notable inventor based in Rio de Janeiro, Brazil. She has made significant contributions to the field of medical research, particularly in the treatment of abnormal concentrations of TNF .alpha. Her innovative work has the potential to impact various medical conditions, including septic shock, cachexia, and HIV infection.
Latest Patents
Elisabeth holds a patent for a method of treating abnormal concentrations of TNF .alpha. The patent describes compounds with specific structures that are effective in controlling TNF .alpha. levels without significantly affecting other cytokines. This advancement is crucial for developing targeted therapies for patients suffering from severe medical conditions.
Career Highlights
Elisabeth P Sampaio is affiliated with The Rockefeller University, where she conducts her research. Her work is characterized by a strong focus on the biochemical mechanisms underlying various diseases. She has dedicated her career to finding innovative solutions to complex medical challenges.
Collaborations
Elisabeth has collaborated with Gilla Kaplan, a fellow researcher, to further explore the implications of her findings. Their partnership exemplifies the importance of teamwork in scientific research and innovation.
Conclusion
Elisabeth P Sampaio's contributions to the field of medical research highlight her role as an innovator in the treatment of TNF .alpha. related conditions. Her patent and ongoing research continue to pave the way for advancements in medical therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile